Atrás
Healios KK (HLOSF) Ganando
Gráfico del Precio de Acciones HLOSF
HLOSF Ganando
Healios KK
$2.7
0%
$0
Al cierre: Mar 25, 16:00:00 GMT-4
$2.7
0%
$0
Mercado Posterior: Mar 25, 20:00:00 GMT-4
Estadísticas clave
Cierre Anterior
$2.7
Precio de apertura
$2.7
Rango del día
$2.7 - $2.7
Rango de 52 semanas
$1.9 - $4.45
Volumen
100
Volumen promedio
20
Rendimiento de dividendos
--
EPS (TTM)
-0.17
Cap. de mercado
$364.5M
¿Qué es HEALIOS K K?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.